Your browser doesn't support javascript.
loading
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Spiegel, Jay Y; Patel, Shabnum; Muffly, Lori; Hossain, Nasheed M; Oak, Jean; Baird, John H; Frank, Matthew J; Shiraz, Parveen; Sahaf, Bita; Craig, Juliana; Iglesias, Maria; Younes, Sheren; Natkunam, Yasodha; Ozawa, Michael G; Yang, Eric; Tamaresis, John; Chinnasamy, Harshini; Ehlinger, Zach; Reynolds, Warren; Lynn, Rachel; Rotiroti, Maria Caterina; Gkitsas, Nikolaos; Arai, Sally; Johnston, Laura; Lowsky, Robert; Majzner, Robbie G; Meyer, Everett; Negrin, Robert S; Rezvani, Andrew R; Sidana, Surbhi; Shizuru, Judith; Weng, Wen-Kai; Mullins, Chelsea; Jacob, Allison; Kirsch, Ilan; Bazzano, Magali; Zhou, Jing; Mackay, Sean; Bornheimer, Scott J; Schultz, Liora; Ramakrishna, Sneha; Davis, Kara L; Kong, Katherine A; Shah, Nirali N; Qin, Haiying; Fry, Terry; Feldman, Steven; Mackall, Crystal L; Miklos, David B.
Afiliación
  • Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Hossain NM; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Oak J; Division of Hematology/Oncology, Loyola University Medical Center, Chicago, IL, USA.
  • Baird JH; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Shiraz P; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Craig J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Iglesias M; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Younes S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Natkunam Y; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Ozawa MG; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Yang E; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Tamaresis J; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Chinnasamy H; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
  • Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Reynolds W; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Lynn R; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Rotiroti MC; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Gkitsas N; Lyell Immunopharma, San Francisco, CA, USA.
  • Arai S; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Johnston L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Lowsky R; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Majzner RG; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Meyer E; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Negrin RS; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Rezvani AR; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Shizuru J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Weng WK; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Mullins C; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Jacob A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Kirsch I; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
  • Bazzano M; Adaptive Biotechnologies, Seattle, WA, USA.
  • Zhou J; Adaptive Biotechnologies, Seattle, WA, USA.
  • Mackay S; Adaptive Biotechnologies, Seattle, WA, USA.
  • Bornheimer SJ; IsoPlexis, Brantford, CT, USA.
  • Schultz L; IsoPlexis, Brantford, CT, USA.
  • Ramakrishna S; IsoPlexis, Brantford, CT, USA.
  • Davis KL; BD Biosciences, San Jose, CA, USA.
  • Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Shah NN; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Qin H; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
  • Fry T; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Feldman S; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Miklos DB; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Nat Med ; 27(8): 1419-1431, 2021 08.
Article en En | MEDLINE | ID: mdl-34312556
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Lectina 2 Similar a Ig de Unión al Ácido Siálico Tipo de estudio: Guideline Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Lectina 2 Similar a Ig de Unión al Ácido Siálico Tipo de estudio: Guideline Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos